First Turn Management’s Axsome Therapeutics AXSM Stock Holding History

First Turn Management's AXSM Position: Q2 2026 in Review

First Turn Management increased its Axsome Therapeutics (AXSM) stake by 16% in Q2 2026, buying an estimated $6.43M and bringing the position to 218,415 shares worth $53.5M. The position accounts for 5.72% of the portfolio, ranked #3.

First Turn Management first reported a position in AXSM in Q4 2023 and has held it in 11 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

• First Turn Management held 218,415 shares of Axsome Therapeutics worth $53.5M as of Q2 2026.
• First Turn Management bought 29,643 Axsome Therapeutics shares in Q2 2026, an estimated $6.43M.
• Axsome Therapeutics made up 5.72% of First Turn Management's portfolio in Q2 2026, its #3 holding.
• First Turn Management first reported a position in Axsome Therapeutics in Q4 2023 and has held it in 11 quarters since.
• 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on First Turn Management's 13F filing for Q2 2026, filed 14 Aug 2026.